Biopharmaceuticals have emerged as an important therapeutic class for treating diseases like cancer, autoimmune, cardiovascular, and infectious diseases. The production of biopharmaceuticals is more complex than that of chemical medicines. The production process is influenced by various factors such as choice of cell lines, harvesting, purification, and further treatment of the finished product. At present, fed-batch is the most preferred process used in manufacturing biopharmaceuticals. However, in the future, the industry is likely to witness greater adoption of continuous processes to improve scalability and facilitate time-to-market while lowering capital and operating costs. Further, there is a change in the trend from using stainless-steel-based equipment to disposable/single-use technology-based equipment to save capital investment and achieve operational flexibility.
In its latest publication on Biopharmaceutical Processing Equipment and Consumables, Meticulous Research states that the global biopharmaceutical processing equipment and consumables market will increase at a CAGR of 10.3% from 2022 to 2029 to reach $70.84 Billion by 2029.
To provide efficient analysis, Meticulous Research has segmented the Biopharmaceutical Processing Equipment And Consumables Market by Product Type (Filtration Systems, Chromatography Equipment and Consumables {Consumables & Equipment}, Bioreactors {Reusable Bioreactors, Disposable/Single-use Bioreactors}, Cell Culture Products {Cell Culture Media [Cell Culture Media, by Physical Form–Dry Powder Media, Liquid Media], [Cell Culture Media, by Type–Off-the-Shelf Media, Custom Media], [Cell Culture Media, by Source-Chemically Defined Media, Natural Media], Reagents and Supplements, Cell and Cell Lines, Serum}, Mixing Systems, Bioprocessing Containers, Sterilizers, Centrifuges, Incubators, Shakers, Biosafety Cabinets, Other Consumables and Accessories, Services), Application (Commercial Bioproduction {Vaccine Manufacturing, mAb Production, Recombinant Protein Production, Cell and Gene Therapy Production}, Research Bioproduction), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations (CDMOs), & Academia and Research Institutes), and Geography.
Download Free Report Sample Now : https://www.meticulousresearch.com/download-sample-report/cp_id=4200
Wherein, geographically, Europe is estimated to command the largest share in this market in 2022, followed by North America. The major share of Europe is mainly attributed to the ample number of biologics drug discovery & development programs, a large number of key biopharmaceutical manufacturers, large bioproduction capacity, and high demand for biopharmaceuticals in the region. However, the Asia-Pacific region is expected to grow with the lucrative CAGR over the forecast period due to the developing bioprocessing hubs in this region, rising developments of biotechnology incubators, and growing initiatives by the public authorities for supporting the adoption of biosimilars.
In terms of product type, filtration systems is estimated to command the largest share of the market in 2022. Filtration systems are widely consumed throughout the biopharmaceutical production process – from liquid clarification to the sterile filtration of the finished product. Accelerated development of single-use filtration systems to meet the growing need for single-use bioprocessing systems. These factors contribute to the largest share of the market.
Based on application, the market is segmented into commercial bioproduction and research bioproduction. The commercial bioproduction segment is estimated growth with the fastest CAGR by 2029. The large adoption of biopharmaceutical equipment and consumables in the commercial production of biopharmaceuticals is a key factor contributing to market growth.
In terms of end user, the pharmaceutical and biopharmaceutical companies segment is estimated to account for the largest share in 2022 due to the factors such as increasing demand for biopharmaceutical products, growing adoption of single-use products, and increasing demand for biopharmaceutical drugs from emerging countries.
Quick Buy Now: https://www.meticulousresearch.com/Checkout/94239620
The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, and geographical presence on some of the key players operating in the global biopharmaceutical processing equipment and consumables market 3M Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).
Key questions answered in the report-
- Which are the high-growth market segments in terms of product type, application, end user, and regions/countries?
- What was the historical market for biopharmaceutical processing equipment and consumables across the globe?
- What are the market forecasts and estimates for the period 2022–2029?
- What are the major drivers, restraints, challenges, opportunities, and trends in the global market of biopharmaceutical processing equipment and consumables?
- Who are the major players in the global biopharmaceutical processing equipment and consumables market?
- How is the competitive landscape, and who are the market leaders in the global biopharmaceutical processing equipment and consumables market?
- What are the recent developments in the biopharmaceutical processing equipment and consumables market?
- What are the different strategies adopted by the major players in the biopharmaceutical processing equipment and consumables market?
- What are the geographical trends and high growth regions/countries?
Speak to Analyst : https://www.meticulousresearch.com/speak-to-analyst/cp_id=4200
Author:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research